Galderma Group AG

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
$22.9B
Website
http://www.galderma.com/

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

First Posted Date
2013-09-26
Last Posted Date
2022-08-23
Lead Sponsor
Galderma R&D
Target Recruit Count
81
Registration Number
NCT01951417
Locations
🇺🇸

Study Protocol, Inc., Boynton Beach, Florida, United States

🇺🇸

Tennessee Clinical Research Center, Nashville, Tennessee, United States

🇺🇸

The Dermatology Clinical Research Center of San Antonio, San Antonio, Texas, United States

and more 2 locations

Safety and Efficacy Study of Lip Injections With Emervel Lips Lidocaine and Juvéderm Volbella With Lidocaine

First Posted Date
2013-08-05
Last Posted Date
2022-08-25
Lead Sponsor
Galderma R&D
Registration Number
NCT01916278
Locations
🇩🇪

Medical Skin Center, Düsseldorf, Germany

🇩🇪

Rosenpark Research, Darmstadt, Germany

🇸🇪

Akademikliniken, Stockholm, Sweden

A Long Term Study of GK530G in Subjects With Acne Vulgaris

Phase 3
Completed
Conditions
Interventions
First Posted Date
2013-07-29
Last Posted Date
2017-03-28
Lead Sponsor
Galderma R&D
Target Recruit Count
436
Registration Number
NCT01910064
Locations
🇯🇵

Galderma investigational site, Fukuoka, Japan

Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin.

First Posted Date
2013-07-26
Last Posted Date
2022-08-23
Lead Sponsor
Galderma R&D
Target Recruit Count
35
Registration Number
NCT01909713
Locations
🇺🇸

RCTS, Inc., Irving, Texas, United States

Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%

Phase 4
Completed
Conditions
Interventions
First Posted Date
2013-07-09
Last Posted Date
2022-09-27
Lead Sponsor
Galderma R&D
Target Recruit Count
28
Registration Number
NCT01893567
Locations
🇺🇸

Hamzavi Dermatology, Fort Gratiot, Michigan, United States

Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test

Phase 4
Completed
Conditions
Interventions
First Posted Date
2013-07-04
Last Posted Date
2022-08-01
Lead Sponsor
Galderma R&D
Target Recruit Count
128
Registration Number
NCT01892657
Locations
🇺🇸

Thomas J. Stephens and Associates, Inc., Colorado Springs, Colorado, United States

Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2013-07-04
Last Posted Date
2022-07-29
Lead Sponsor
Galderma R&D
Target Recruit Count
146
Registration Number
NCT01892423
Locations
🇺🇸

Thomas J Stephens and Associates Inc, Carrollton, Texas, United States

Patch Test Skin Irritation/Sensitization of Cetaphil Restoraderm Skin Restoring Body Wash

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2013-07-04
Last Posted Date
2022-07-29
Lead Sponsor
Galderma R&D
Target Recruit Count
100
Registration Number
NCT01892410
Locations
🇺🇸

AMA Laboratories, Inc., New City, New York, United States

Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2013-06-28
Last Posted Date
2022-07-29
Lead Sponsor
Galderma R&D
Target Recruit Count
200
Registration Number
NCT01888887
Locations
🇺🇸

AMA Laboratories, New City, New York, United States

Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2013-06-27
Last Posted Date
2022-07-29
Lead Sponsor
Galderma R&D
Target Recruit Count
100
Registration Number
NCT01887860
Locations
🇺🇸

AMA Laboratories, New City, New York, United States

© Copyright 2024. All Rights Reserved by MedPath